CELGENE QUANTICEL RESEARCH INC has a total of 43 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2013. It filed its patents most often in Australia, Taiwan and Singapore. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are RELAY THERAPEUTICS INC, ONCOBIX CO LTD and ABAC THERAPEUTICS S L.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 21 | |
#2 | Taiwan | 9 | |
#3 | Singapore | 7 | |
#4 | Serbia | 5 | |
#5 | EAPO (Eurasian Patent Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Organic chemistry methods | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Enzymes | |
#8 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Stafford Jeffrey Alan | 31 |
#2 | Veal James Marvin | 25 |
#3 | Kanouni Toufike | 18 |
#4 | Chen Young K | 14 |
#5 | Betancort Juan Manuel | 11 |
#6 | Boloor Amogh | 11 |
#7 | Kaldor Stephen W | 10 |
#8 | Wallace Michael Brennan | 7 |
#9 | Bennett Michael John | 7 |
#10 | Cho Robert | 7 |
Publication | Filing date | Title |
---|---|---|
AU2017252276A1 | Therapeutic compounds | |
AU2016349707A1 | Compositions comprising an inhibitor of lysine specific demethylase-1 |